Synapse Technologies Overview
- Founded
- 1992
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Latest Deal Amount
- $15.3M
Synapse Technologies General Information
Description
Developer of proprietary technology to deliver therapeutic enzymes and other drugs. The company focuses on discovery, development and commercialization of transport systems for therapeutic drug delivery across the blood brain barrier and new drug targets in neurodegenerative disease.
Contact Information
Primary Industry
Drug Delivery
Acquirer
Primary Office
- 6660 NorthWest Marine Drive
- Vancouver, British Columbia B6T 1Z4
- Canada
Synapse Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 21-Mar-2002 | $15.3M | 000 | 000.00 | Completed | Clinical Trials - General |
| 1. Later Stage VC | 12-Jan-2000 | 000 | 000 | Completed | Startup |
Synapse Technologies Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Z Ruttonsha | Chief Executive Officer & President |
Synapse Technologies Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| BDC Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| BMO Financial Group | Lender/Debt Provider | Minority | 000 0000 | 000000 0 | |
| FutureFund Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| GrowthWorks | Venture Capital | Minority | 000 0000 | 000000 0 | |
| MDS Ventures Pacific | Minority | 000 0000 | 000000 0 |